Cover Image
市場調查報告書

體外毒性實驗的全球市場預測 2021年:全身毒性、經皮毒性、致癌性、眼毒性、皮膚敏感性/刺激性、遺傳毒性、神經毒性、內臟器官毒性

In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical): Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 298990
出版日期 內容資訊 英文 258 Pages
訂單完成後即時交付
價格
Back to Top
體外毒性實驗的全球市場預測 2021年:全身毒性、經皮毒性、致癌性、眼毒性、皮膚敏感性/刺激性、遺傳毒性、神經毒性、內臟器官毒性 In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical): Global Forecast to 2021
出版日期: 2016年06月03日 內容資訊: 英文 258 Pages
簡介

全球體外毒性測試市場規模,預計從2016年的141億5,000萬美元到2021年達到273億6,000萬美元,從2016年到2021年的年複合成長率預計為14.1%。該市場的成長主要由於反對動物檢驗,新的、有前途的技術,初期階段查出毒性的R&D的增加,及體外實驗手法的利用所促進,透過不完全的資料庫推動。

本報告提供全球體外毒性測試市場的相關調查,市場概要,產業趨勢,各產品、種類、毒性試驗指標實驗、技術、手法、產業、地區的市場分析,競爭情形,並提供主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 值得一提的考察點

  • 全球體外毒性測試市場概要
  • 體外毒性測試市場:各技術、地區
  • 體外毒性測試市場:地區概要
  • 生命週期分析:各地區

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 威脅

第6章 產業考察

  • 簡介
  • 主要的重點領域
  • 供應鏈分析
  • 波特的五力分析
  • 法規委員會的活動

第7章 體外毒性測試市場:各產品

  • 簡介
  • 化驗
  • 服務
  • 試劑 & 實驗設備

第8章 體外毒性測試市場:各類型

  • 簡介
  • ADME (吸收、分佈、代謝、排泄)
  • 投藥
    • 用量反應
    • 限制反應
  • 毒物

第9章 體外毒性測試市場:毒性試驗指標、實驗

  • 簡介
  • 全身毒性
  • 經皮毒性
  • 致癌性
  • 眼毒性
  • 皮膚敏感性、皮膚刺激性
  • 遺傳毒性
  • 神經毒性
  • 內臟器官毒性
  • 其他毒性試驗指標、實驗

第10章 體外毒性測試市場:各技術

  • 簡介
  • 體學技術
    • 基因學
    • 蛋白質體學
    • 代謝體學
    • 轉錄體學
    • 毒理基因體學 (毒性基因學)
  • 細胞培養技術
  • 高通量技術
  • 分子影像技術

第11章 體外毒性測試市場:各手法

  • 簡介
  • In Silico手法 (電腦分析)
  • 生物化學分析
  • 細胞分析
  • 體外 (EX VIVO) 模式

第12章 體外毒性測試市場:各產業

  • 簡介
  • 化妝品、家用品
  • 診斷
    • 尿液檢查
    • 酒精檢驗
    • 口腔液檢驗
    • 毛髮檢驗
    • 其他
  • 醫藥品
  • 食品產業
  • 化學品

第13章 體外毒性測試市場:各地區

  • 簡介
  • 歐洲
  • 北美
    • 美國
    • 加拿大
  • 亞洲
  • 其他地區

第14章 競爭環境

  • 簡介
  • 策略分析
  • 體外毒性測試市場的主要企業
  • 競爭情形、趨勢

第15章 企業簡介

  • 簡介
  • AGILENT TECHNOLOGIES, INC.
  • COVANCE
  • BIO-RAD LABORATORIES, INC.
  • GENERAL ELECTRIC COMPANY
  • EUROFINS SCIENTIFIC SE
  • BIORELIANCE, INC. (A SUBSIDIARY OF MERCK & CO, INC.)
  • THERMO FISHER SCIENTIFIC, INC.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • CATALENT
  • CYPROTEX

第16章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2373

The global in vitro toxicology testing market is expected to USD 27.36 billion by 2021 from USD 14.15 billion in 2016, at a CAGR of 14.1% between 2016 and 2021. By product, the market includes assays, reagents & labware, and services. Based on toxicity endpoints & tests, the market is segmented into systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & irritation, genotoxicity, neurotoxicity, and organ toxicity. The systemic toxicity segment will hold the largest share of the in vitro toxicology testing toxicity endpoints & tests market in 2016.

The geographic segments included in this report are Europe, North America, Asia, and Rest of the World (RoW). Europe is expected to account for the largest share in the global the in vitro toxicology testing market in 2016. Asia is expected to register the fastest growth in the forecast period.

The growth of this market is mainly driven by opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods. In addition, growing demand for in vitro toxicology in the European market and increasing drug discovery and innovation, & modernization in the in vitro toxicity testing market provides a growing opportunity to this market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global in vitro toxicology testing market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders such as Agilent Technologies, Inc. (U.S.), Covance, Inc. (A subsidiary of LabCorp) (U.S.), Bio-Rad Laboratories, Inc. (U.S.), General Electric Company (U.S.), Eurofins Scientific SE (Luxembourg), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.).

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of the top players in the in vitro toxicology testing market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the in vitro toxicology testing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various in vitro toxicology testing across geographies
  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the in vitro toxicology testing market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SEGMENTATION
    • 1.3.1. YEARS CONSIDERED IN THE REPORT
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL IN VITRO TOXICOLOGY TESTING MARKET OVERIEW
  • 4.2. IN VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY & REGION
  • 4.3. IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4. LIFE CYCLE ANALYSIS, BY REGION (2016)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Opposition to animal testing
      • 5.3.1.2. New and promising technologies
      • 5.3.1.3. Increasing R&D to detect toxicity at early stages
      • 5.3.1.4. Insufficient databases to facilitate the use of in vitro test methods
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Predictive ability of in vitro testing leads to decreasing adoption of these tests
      • 5.3.2.2. Lack of in vitro models to detect autoimmunity & immunostimulation
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Growing demand for in vitro toxicology in the European market
      • 5.3.3.2. Toxicology in the 21st century (Tox21) program
      • 5.3.3.3. Increasing drug discovery and innovation & modernization in the in vitro toxicity testing market
    • 5.3.4. THREAT
      • 5.3.4.1. Reluctance of regulatory authorities to consider alternate methods for proving safety and efficacy

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
    • 6.1.1. INCREASING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY SECTOR
  • 6.2. KEY FOCUS AREA
    • 6.2.1. NEW AND PROMISING TECHNOLOGICAL ADVANCEMENTS A KEY AREA OF FOCUS FOR MARKET PLAYERS
  • 6.3. SUPPLY CHAIN ANALYSIS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. THREAT FROM NEW ENTRANTS
    • 6.4.2. THREAT FROM SUBSTITUTES
    • 6.4.3. BARGAINING POWER OF SUPPLIERS
    • 6.4.4. BARGAINING POWER OF BUYERS
    • 6.4.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.5. REGULATORY COMMITTEE ACTIVITIES

7. IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. ASSAYS
    • 7.2.1. BACTERIAL TOXICITY ASSAYS
    • 7.2.2. ENZYME TOXICITY ASSAYS
    • 7.2.3. CELL-BASED ELISA AND WESTERN BLOTS
    • 7.2.4. RECEPTOR-BINDING ASSAYS
    • 7.2.5. TISSUE CULTURE ASSAYS
    • 7.2.6. OTHER ASSAYS
  • 7.3. SERVICES
  • 7.4. REAGENTS & LABWARE

8. IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE

  • 8.1. INTRODUCTION
  • 8.2. ADME (ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION)
  • 8.3. DOSE
    • 8.3.1. DOSE RESPONSE
    • 8.3.2. THRESHOLD RESPONSE
  • 8.4. TOXIC SUBSTANCE

9. IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINTS & TESTS

  • 9.1. INTRODUCTION
  • 9.2. SYSTEMIC TOXICITY
  • 9.3. DERMAL TOXICITY
  • 9.4. CARCINOGENICITY
  • 9.5. OCULAR TOXICITY
  • 9.6. SKIN SENSITIZATION & IRRITATION
  • 9.7. GENOTOXICITY
  • 9.8. NEUROTOXICITY
  • 9.9. ORGAN TOXICITY
  • 9.10. OTHER TOXICITY ENDPOINTS & TESTS

10. IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY

  • 10.1. INTRODUCTION
  • 10.2. OMICS TECHNOLOGIES
    • 10.2.1. GENOMICS
    • 10.2.2. PROTEOMICS
    • 10.2.3. METABOLOMICS
    • 10.2.4. TRANSCRIPTOMICS
    • 10.2.5. TOXICOGENOMICS
  • 10.3. CELL CULTURE TECHNOLOGY
  • 10.4. HIGH-THROUGHPUT TECHNOLOGIES
  • 10.5. MOLECULAR IMAGING TECHNOLOGIES

11. IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD

  • 11.1. INTRODUCTION
  • 11.2. IN SILICO METHODS
  • 11.3. BIOCHEMICAL ASSAYS
  • 11.4. CELLULAR ASSAYS
  • 11.5. EX VIVO MODELS

12. IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY

  • 12.1. INTRODUCTION
  • 12.2. COSMETICS AND HOUSEHOLD PRODUCTS
  • 12.3. DIAGNOSTICS
    • 12.3.1. URINE SCREENING
    • 12.3.2. ALCOHOL SCREENING
    • 12.3.3. ORAL FLUID SCREENING
    • 12.3.4. HAIR SCREENING
    • 12.3.5. OTHERS
  • 12.4. PHARMACEUTICALS
  • 12.5. FOOD INDUSTRY
  • 12.6. CHEMICALS

13. IN VITRO TOXICOLOGY TESTING MARKET, BY REGION

  • 13.1. INTRODUCTION
  • 13.2. EUROPE
  • 13.3. NORTH AMERICA
    • 13.3.1. U.S.
    • 13.3.2. CANADA
  • 13.4. ASIA
  • 13.5. REST OF THE WORLD

14. COMPETITIVE LANDSCAPE

  • 14.1. INTRODUCTION
  • 14.2. STRATEGIC ANALYSIS
  • 14.3. LEADING PLAYERS IN THE IN VITRO TOXICOLOGY TESTING MARKET
  • 14.4. COMPETITIVE SITUATION AND TRENDS
    • 14.4.1. NEW PRODUCT LAUNCHES AND PRODUCT UPGRADES
    • 14.4.2. ACQUISITION
    • 14.4.3. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 14.4.4. NEW SERVICE LAUNCH
    • 14.4.5. EXPANSION
    • 14.4.6. OTHER DEVELOPMENTS

15. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 15.1. INTRODUCTION
  • 15.2. AGILENT TECHNOLOGIES, INC.
  • 15.3. COVANCE
  • 15.4. BIO-RAD LABORATORIES, INC.
  • 15.5. GENERAL ELECTRIC COMPANY
  • 15.6. EUROFINS SCIENTIFIC SE
  • 15.7. BIORELIANCE, INC. (A SUBSIDIARY OF MERCK KGAA)
  • 15.8. THERMO FISHER SCIENTIFIC, INC.
  • 15.9. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 15.10. CATALENT
  • 15.11. CYPROTEX

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

16. APPENDIX

  • 16.1. INSIGHTS OF INDUSTRY EXPERTS
  • 16.2. DISCUSSION GUIDE
  • 16.3. OTHER DEVELOPMENTS
  • 16.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 16.6. AVAILABLE CUSTOMIZATIONS
  • 16.7. RELATED REPORTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SEGMENTATION
    • 1.3.1. YEARS CONSIDERED IN THE REPORT
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL IN VITRO TOXICOLOGY TESTING MARKET OVERIEW
  • 4.2. IN VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY & REGION
  • 4.3. IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4. LIFE CYCLE ANALYSIS, BY REGION (2016)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Opposition to animal testing
      • 5.3.1.2. New and promising technologies
      • 5.3.1.3. Increasing R&D to detect toxicity at early stages
      • 5.3.1.4. Insufficient databases to facilitate the use of in vitro test methods
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Predictive ability of in vitro testing leads to decreasing adoption of these tests
      • 5.3.2.2. Lack of in vitro models to detect autoimmunity & immunostimulation
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Growing demand for in vitro toxicology in the European market
      • 5.3.3.2. Toxicology in the 21st century (Tox21) program
      • 5.3.3.3. Increasing drug discovery and innovation & modernization in the in vitro toxicity testing market
    • 5.3.4. THREAT
      • 5.3.4.1. Reluctance of regulatory authorities to consider alternate methods for proving safety and efficacy

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
    • 6.1.1. INCREASING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY SECTOR
  • 6.2. KEY FOCUS AREA
    • 6.2.1. NEW AND PROMISING TECHNOLOGICAL ADVANCEMENTS A KEY AREA OF FOCUS FOR MARKET PLAYERS
  • 6.3. SUPPLY CHAIN ANALYSIS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. THREAT FROM NEW ENTRANTS
    • 6.4.2. THREAT FROM SUBSTITUTES
    • 6.4.3. BARGAINING POWER OF SUPPLIERS
    • 6.4.4. BARGAINING POWER OF BUYERS
    • 6.4.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.5. REGULATORY COMMITTEE ACTIVITIES

7. IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. ASSAYS
    • 7.2.1. BACTERIAL TOXICITY ASSAYS
    • 7.2.2. ENZYME TOXICITY ASSAYS
    • 7.2.3. CELL-BASED ELISA AND WESTERN BLOTS
    • 7.2.4. RECEPTOR-BINDING ASSAYS
    • 7.2.5. TISSUE CULTURE ASSAYS
    • 7.2.6. OTHER ASSAYS
  • 7.3. SERVICES
  • 7.4. REAGENTS & LABWARE

8. IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE

  • 8.1. INTRODUCTION
  • 8.2. ADME (ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION)
  • 8.3. DOSE
    • 8.3.1. DOSE RESPONSE
    • 8.3.2. THRESHOLD RESPONSE
  • 8.4. TOXIC SUBSTANCE

9. IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINTS & TESTS

  • 9.1. INTRODUCTION
  • 9.2. SYSTEMIC TOXICITY
  • 9.3. DERMAL TOXICITY
  • 9.4. CARCINOGENICITY
  • 9.5. OCULAR TOXICITY
  • 9.6. SKIN SENSITIZATION & IRRITATION
  • 9.7. GENOTOXICITY
  • 9.8. NEUROTOXICITY
  • 9.9. ORGAN TOXICITY
  • 9.10. OTHER TOXICITY ENDPOINTS & TESTS

10. IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY

  • 10.1. INTRODUCTION
  • 10.2. OMICS TECHNOLOGIES
    • 10.2.1. GENOMICS
    • 10.2.2. PROTEOMICS
    • 10.2.3. METABOLOMICS
    • 10.2.4. TRANSCRIPTOMICS
    • 10.2.5. TOXICOGENOMICS
  • 10.3. CELL CULTURE TECHNOLOGY
  • 10.4. HIGH-THROUGHPUT TECHNOLOGIES
  • 10.5. MOLECULAR IMAGING TECHNOLOGIES

11. IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD

  • 11.1. INTRODUCTION
  • 11.2. IN SILICO METHODS
  • 11.3. BIOCHEMICAL ASSAYS
  • 11.4. CELLULAR ASSAYS
  • 11.5. EX VIVO MODELS

12. IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY

  • 12.1. INTRODUCTION
  • 12.2. COSMETICS AND HOUSEHOLD PRODUCTS
  • 12.3. DIAGNOSTICS
    • 12.3.1. URINE SCREENING
    • 12.3.2. ALCOHOL SCREENING
    • 12.3.3. ORAL FLUID SCREENING
    • 12.3.4. HAIR SCREENING
    • 12.3.5. OTHERS
  • 12.4. PHARMACEUTICALS
  • 12.5. FOOD INDUSTRY
  • 12.6. CHEMICALS

13. IN VITRO TOXICOLOGY TESTING MARKET, BY REGION

  • 13.1. INTRODUCTION
  • 13.2. EUROPE
  • 13.3. NORTH AMERICA
    • 13.3.1. U.S.
    • 13.3.2. CANADA
  • 13.4. ASIA
  • 13.5. REST OF THE WORLD

14. COMPETITIVE LANDSCAPE

  • 14.1. INTRODUCTION
  • 14.2. STRATEGIC ANALYSIS
  • 14.3. LEADING PLAYERS IN THE IN VITRO TOXICOLOGY TESTING MARKET
  • 14.4. COMPETITIVE SITUATION AND TRENDS
    • 14.4.1. NEW PRODUCT LAUNCHES AND PRODUCT UPGRADES
    • 14.4.2. ACQUISITION
    • 14.4.3. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 14.4.4. NEW SERVICE LAUNCH
    • 14.4.5. EXPANSION
    • 14.4.6. OTHER DEVELOPMENTS

15. COMPANY PROFILES

(Overview, Products and Services, Financials, Strategy & Development)*

  • 15.1. INTRODUCTION
  • 15.2. AGILENT TECHNOLOGIES, INC.
  • 15.3. COVANCE
  • 15.4. BIO-RAD LABORATORIES, INC.
  • 15.5. GENERAL ELECTRIC COMPANY
  • 15.6. EUROFINS SCIENTIFIC SE
  • 15.7. BIORELIANCE, INC. (A SUBSIDIARY OF MERCK KGAA)
  • 15.8. THERMO FISHER SCIENTIFIC, INC.
  • 15.9. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 15.10. CATALENT
  • 15.11. CYPROTEX

Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

16. APPENDIX

  • 16.1. INSIGHTS OF INDUSTRY EXPERTS
  • 16.2. DISCUSSION GUIDE
  • 16.3. OTHER DEVELOPMENTS
  • 16.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 16.6. AVAILABLE CUSTOMIZATIONS
  • 16.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: IN VITRO TOXICOLOGY TESTING MARKET SUMMARY
  • TABLE 2: OPPOSITION TO ANIMAL TESTING IS PROPELLING THE GROWTH OF THE IN VITRO TOXICOLOGY TESTING MARKET
  • TABLE 3: PREDICTIVE ABILITY OF IN VITRO TESTING LEADING TO THE DECREASING ADOPTION OF IN VITRO TESTS IS RESTRICTING MARKET GROWTH
  • TABLE 4: NEW RESEARCH INITIATIVES AND GROWING DEMAND FOR IN VITRO TOXICOLOGY IN THE EUROPEAN MARKET TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR PLAYERS IN THE IN VITRO TOXICOLOGY TESTING MARKET
  • TABLE 5: RELUCTANCE OF REGULATORY AUTHORITIES TO CONSIDER ALTERNATE METHODS IS A MAJOR THREAT FOR THIS MARKER
  • TABLE 6: IN VITRO TOXICOLOGY TESTING INDUSTRY FOCUSING ON TECHNOLOGICAL ADVANCEMENTS TO DRIVE TOXICITY ENDPOINTS TESTING
  • TABLE 7: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 8: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR ASSAYS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 9: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR BACTERIAL TOXICITY ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: IN VITRO TOXICITY TESTING MARKET SIZE FOR ENZYME TOXICITY ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR CELL-BASED ELISA AND WESTERN BLOTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR RECEPTOR-BINDING ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR TISSUE CULTURE ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR OTHER ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR SERVICES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR REAGENTS & LABWARE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR ADME, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR DOSE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 21: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR DOSE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR DOSE RESPONSE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR THRESHOLD RESPONSE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR TOXIC SUBSTANCES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TOXICITY ENDPOINT & TEST, 2014-2021 (USD MILLION)
  • TABLE 26: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR SYSTEMIC TOXICITY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR DERMAL TOXICITY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR CARCINOGENICITY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR OCULAR TOXICITY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR SKIN SENSITIZATION & IRRITATION MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR GENOTOXICITY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR NEUROTOXICITY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR ORGAN TOXICITY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR OTHER TOXICITY ENDPOINTS & TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 36: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR OMICS TECHNOLOGIES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 37: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR OMICS TECHNOLOGIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR GENOMICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR PROTEOMICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR METABOLOMICS MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR TRANSCRIPTOMICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR TOXICOGENOMICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR CELL CULTURE TECHNOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 44: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR HIGH-THROUGHPUT TECHNOLOGIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR MOLECULAR IMAGING TECHNOLOGIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 47: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR IN SILICO METHODS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 48: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR BIOCHEMICAL ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 49: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR CELLULAR ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR EX VIVO ASSAYS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY INDUSTRY, 2014-2021 (USD MILLION)
  • TABLE 52: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR COSMETICS & HOUSEHOLD PRODUCTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 53: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR DIAGNOSTICS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR DIAGNOSTICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR URINE SCREENING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR ALCOHOL SCREENING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR ORAL FLUID SCREENING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 58: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR HAIR SCREENING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR OTHER DIAGNOSTICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR PHARMACEUTICALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR THE FOOD INDUSTRY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR THE CHEMICAL INDUSTRY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 63: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 64: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TOXICITY ENDPOINT & TEST, 2014-2021 (USD MILLION)
  • TABLE 67: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 68: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 69: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY INDUSTRY, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 71: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 72: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TOXICITY ENDPOINT & TEST, 2014-2021 (USD MILLION)
  • TABLE 74: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 75: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 76: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY INDUSTRY, 2014-2021 (USD MILLION)
  • TABLE 77: U.S.: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 78: U.S.: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: U.S.: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TOXICITY ENDPOINT & TEST, 2014-2021 (USD MILLION)
  • TABLE 80: U.S.: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 81: U.S.: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 82: U.S.: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY INDUSTRY, 2014-2021 (USD MILLION)
  • TABLE 83: CANADA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 84: CANADA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: CANADA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TOXICITY ENDPOINT & TEST, 2014-2021 (USD MILLION)
  • TABLE 86: CANADA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 87: CANADA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 88: CANADA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY INDUSTRY, 2014-2021 (USD MILLION)
  • TABLE 89: ASIA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 90: ASIA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 91: ASIA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TOXICITY ENDPOINT & TEST, 2014-2021 (USD MILLION)
  • TABLE 92: ASIA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 93: ASIA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 94: ASIA: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY INDUSTRY, 2014-2021 (USD MILLION)
  • TABLE 95: ROW: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 12014-2021 (USD MILLION)
  • TABLE 96: ROW: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: ROW: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TOXICITY ENDPOINT & TEST, 2014-2021 (USD MILLION)
  • TABLE 98: ROW: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 99: ROW: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
  • TABLE 100: ROW: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY INDUSTRY, 2014-2021 (USD MILLION)
  • TABLE 101: MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND MAY 2016
  • TABLE 102: NEW PRODUCT LAUNCHES AND PRODUCT UPGRADES, 2013-2016
  • TABLE 103: ACQUISITIONS, 2013-2016
  • TABLE 104: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2016
  • TABLE 105: NEW SERVICE LAUNCH, 2013-2016
  • TABLE 106: EXPANSIONS, 2013-2016
  • TABLE 107: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 7: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TOXICITY ENDPOINTS & TESTS, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY INDUSTRY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 12: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2016 (USD MILLION)
  • FIGURE 13: IN VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 14: INCREASE IN R&D SPENDING TO DRIVE MARKET GROWTH
  • FIGURE 15: OMICS TECHNOLOGIES TO COMMAND THE LARGEST MARKET SHARE IN 2016
  • FIGURE 16: ASIA TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES IN THE IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 18: IN VITRO TOXICOLOGY TESTING MARKET SEGMENTATION
  • FIGURE 19: OPPOSITION TO ANIMAL TESTING WILL DRIVE THE IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 20: INCREASING R&D INVESTMENTS IN THE PHARMA INDUSTRY BOOSTING THE GROWTH OF THE IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 21: DIRECT DISTRIBUTION, THE PREFERRED STRATEGY BY PROMINENT COMPANIES
  • FIGURE 22: PORTER'S FIVE FORCES ANALYSIS (2016): PRESENCE OF LARGE NUMBER OF MANUFACTURING FIRMS INCREASES COMPETITION
  • FIGURE 23: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT
  • FIGURE 24: ASSAYS SEGMENT COMMANDS THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING MARKET IN 2016
  • FIGURE 25: BACTERIAL TOXICITY ASSAYS COMMAND THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS IN 2016
  • FIGURE 26: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE ASSAYS MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: EUROPE WILL BE THE LARGEST REGIONAL SEGMENT IN THE BACTERIAL TOXICITY ASSAYS MARKET
  • FIGURE 28: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE ENZYME TOXICITY ASSAYS MARKET DURING THE FORECAST PERIOD
  • FIGURE 29: EUROPE WILL BE THE LARGEST REGIONAL SEGMENT IN THE CELL-BASED ELISA AND WESTERN BLOTS IN 2016
  • FIGURE 30: ASIA, THE FASTEST-GROWING REGIONAL SEGMENT IN THE IN VITRO TOXICOLOGY TESTING MARKET FOR RECEPTOR-BINDING ASSAYS DURING THE FORECAST PERIOD
  • FIGURE 31: EUROPE, THE LARGEST REGIONAL SEGMENT IN THE IN VITRO TOXICOLOGY TESTING MARKET FOR TISSUE CULTURE ASSAYS IN 2016
  • FIGURE 32: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER ASSAYS DURING THE FORECAST PERIOD
  • FIGURE 33: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE IN VITRO TOXICOLOGY TESTING MARKET FOR SERVICES DURING THE FORECAST PERIOD
  • FIGURE 34: EUROPE COMMANDS THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING MARKET FOR REAGENTS & LABWARE IN 2016
  • FIGURE 35: ADME TO COMMAND THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING TYPE MARKET IN 2016
  • FIGURE 36: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE ADME MARKET IN 2016
  • FIGURE 37: DOSE RESPONSE TO COMMAND THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING MARKET IN 2016
  • FIGURE 38: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE DOSE MARKET DURING THE FORECAST PERIOD
  • FIGURE 39: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE DOSE RESPONSE MARKET IN 2016
  • FIGURE 40: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE THRESHOLD DOSE MARKET DURING THE FORECAST PERIOD
  • FIGURE 41: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE TOXIC SUBSTANCE MARKET IN 2016
  • FIGURE 42: SYSTEMIC TOXICITY TO COMMAND THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING MARKET IN 2016
  • FIGURE 43: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE SYSTEMIC TOXICITY MARKET IN 2016
  • FIGURE 44: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE DERMAL TOXICITY MARKET IN 2016
  • FIGURE 45: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE CARCINOGENICITY MARKET IN 2016
  • FIGURE 46: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE OCULAR TOXICITY MARKET DURING THE FORECAST PERIOD
  • FIGURE 47: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF SKIN SENSITIZATION & IRRITATION MARKET IN 2016
  • FIGURE 48: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE GENOTOXICITY MARKET DURING THE FORECAST PERIOD
  • FIGURE 49: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE NEUROTOXICITY MARKET IN 2016
  • FIGURE 50: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE ORGAN TOXICITY MARKET DURING THE FORECAST PERIOD
  • FIGURE 51: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE OTHER TOXICITY ENDPOINTS & TESTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 52: OMICS TECHNOLOGIES TO COMMAND THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING TECHNOLOGY MARKET IN 2016
  • FIGURE 53: GENOMICS TO COMMAND THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING OMICS TECHNOLOGIES MARKET IN 2016
  • FIGURE 54: EUROPE TO COMMAND THE LARGEST SHARE OF THE OMICS TECHNOLOGIES SEGMENT IN 2016
  • FIGURE 55: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE GENOMICS MARKET IN 2016
  • FIGURE 56: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE PROTEOMICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 57: EUROPE, THE LARGEST REGIONAL SEGMENT OF THE METABOLOMICS MARKET IN 2016
  • FIGURE 58: ASIA, THE FASTEST-GROWING REGIONAL SEGMENT IN THE TRANSCRIPTOMICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 59: EUROPE TO DOMINATE THE TOXICOGENOMICS MARKET IN THE FORECAST PERIOD IN 2016
  • FIGURE 60: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE CELL CULTURE TECHNOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 61: EUROPE TO COMMAND THE LARGEST SHARE OF THE HIGH-THROUGHPUT TECHNOLOGIES SEGMENT IN 2016
  • FIGURE 62: EUROPE TO COMMAND THE LARGEST SHARE OF THE MOLECULAR IMAGING TECHNOLOGIES SEGMENT IN 2016
  • FIGURE 63: IN SILICO METHODS TO COMMAND THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING METHOD MARKET IN 2016
  • FIGURE 64: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE IN SILICO METHODS MARKET DURING THE FORECAST PERIOD
  • FIGURE 65: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE BIOCHEMICAL ASSAYS MARKET IN 2016
  • FIGURE 66: EUROPE TO FORM THE LARGEST REGIONAL SEGMENT OF THE CELLULAR ASSAYS MARKET IN 2016
  • FIGURE 67: ASIA WILL BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE EX VIVO MODELS MARKET DURING THE FORECAST PERIOD
  • FIGURE 68: COSMETICS & HOUSEHOLD PRODUCTS WILL BE THE LARGEST INDUSTRY SEGMENT IN 2016
  • FIGURE 69: ASIA, THE FASTEST-GROWING REGIONAL SEGMENT IN THE IN VITRO TOXICOLOGY TESTING MARKET FOR COSMETICS & HOUSEHOLD PRODUCTS DURING THE FORECAST PERIOD
  • FIGURE 70: URINE SCREENING SEGMENT COMMANDS THE LARGEST SHARE OF THE IN VITRO TOXICOLOGY TESTING MARKET FOR DIAGNOSTICS IN 2016
  • FIGURE 71: ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT IN THE DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 72: EUROPE WILL BE THE LARGEST REGIONAL SEGMENT IN THE URINE SCREENING MARKET BETWEEN 2016 AND 2021
  • FIGURE 73: EUROPE WILL BE THE LARGEST REGIONAL SEGMENT IN THE ALCOHOL SCREENING MARKET BETWEEN 2016 AND 2021
  • FIGURE 74: EUROPE WILL BE THE LARGEST REGIONAL SEGMENT IN THE ORAL FLUID SCREENING MARKET BETWEEN 2016 AND 2021
  • FIGURE 75: EUROPE WILL BE THE LARGEST REGIONAL SEGMENT IN THE HAIR SCREENING MARKET BETWEEN 2016 AND 2021
  • FIGURE 76: EUROPE WILL BE THE LARGEST REGIONAL SEGMENT IN THE OTHER DIAGNOSTICS MARKET BETWEEN 2016 AND 2021
  • FIGURE 77: ASIA TO WITNESS HIGHEST GROWTH IN THE IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICALS DURING THE FORECAST PERIOD
  • FIGURE 78: EUROPE TO COMMAND THE LARGEST SHARE OF THE FOOD INDUSTRY SEGMENT IN 2016
  • FIGURE 79: EUROPE TO COMMAND THE LARGEST SHARE OF THE CHEMICALS SEGMENT IN 2016
  • FIGURE 80: IN VITRO TOXICOLOGY TESTING MARKET SEGMENTATION, BY REGION: MARKET SIZE AND GROWTH RATE, 2016-2021
  • FIGURE 81: ASIAN MARKET TO GROW AT THE HIGHEST RATE (2016 TO 2021)
  • FIGURE 82: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT (2016)
  • FIGURE 83: ASSAYS, THE LARGEST PRODUCT SEGMENT IN EUROPE IN 2016
  • FIGURE 84: ADME SEGMENT DOMINATES THE EUROPEAN IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE
  • FIGURE 85: SYSTEMIC TOXICITY, THE LARGEST TOXICITY ENDPOINT & TEST SEGMENT IN EUROPE
  • FIGURE 86: OMICS TECHNOLOGIES COMMAND LARGEST SHARE OF THE EUROPEAN MARKET IN 2016
  • FIGURE 87: IN SILICO METHODS, THE LARGEST METHODS SEGMENT IN EUROPE
  • FIGURE 88: COSMETICS & HOUSEHOLD PRODUCTS SEGMENT COMMANDS LARGEST SHARE OF THE EUROPEAN MARKET IN 2016
  • FIGURE 89: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 90: CANADA TO GROW AT THE HIGHEST RATE IN NORTH AMERICA
  • FIGURE 91: ASSAYS, THE LARGEST PRODUCT SEGMENT IN NORTH AMERICA IN 2016
  • FIGURE 92: ADME SEGMENT DOMINATES THE NORTH AMERICAN IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 93: SYSTEMIC TOXICITY, THE LARGEST TOXICITY ENDPOINTS & TESTS SEGMENT IN NORTH AMERICA IN 2016
  • FIGURE 94: OMICS TECHNOLOGIES SEGMENT COMMANDS LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2016
  • FIGURE 95: IN SILICO METHODS, THE LARGEST METHOD SEGMENT IN NORTH AMERICA
  • FIGURE 96: COSMETICS & HOUSEHOLD PRODUCTS SEGMENT COMMANDS LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2016
  • FIGURE 97: ASSAYS, THE LARGEST PRODUCT SEGMENT IN THE U.S. IN 2016
  • FIGURE 98: ADME SEGMENT DOMINATES THE U.S. IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 99: SYSTEMIC TOXICITY, THE LARGEST TOXICITY ENDPOINTS & TESTS SEGMENT IN U.S. IN 2016
  • FIGURE 100: OMICS TECHNOLOGIES SEGMENT COMMANDS LARGEST SHARE OF THE U.S. MARKET IN 2016
  • FIGURE 101: IN SILICO METHODS, THE LARGEST METHODS SEGMENT IN THE U.S.
  • FIGURE 102: COSMETICS & HOUSEHOLD PRODUCTS SEGMENT COMMANDS LARGEST SHARE OF THE U.S. MARKET IN 2016
  • FIGURE 103: ASSAYS, THE LARGEST PRODUCT SEGMENT IN CANADA IN 2016
  • FIGURE 104: ADME SEGMENT DOMINATES THE CANADA IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 105: SYSTEMIC TOXICITY, THE LARGEST TOXICITY ENDPOINTS & TESTS SEGMENT IN CANADA IN 2016
  • FIGURE 106: OMICS TECHNOLOGIES SEGMENT COMMANDS LARGEST SHARE OF THE CANADA MARKET IN 2016
  • FIGURE 107: IN SILICO METHODS, THE LARGEST METHODS SEGMENT IN CANADA
  • FIGURE 108: COSMETICS & HOUSEHOLD PRODUCTS SEGMENT COMMANDS LARGEST SHARE OF THE CANADA MARKET IN 2016
  • FIGURE 109: ASIA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 110: ASSAYS, THE LARGEST PRODUCT SEGMENT IN ASIA IN 2016
  • FIGURE 111: ADME SEGMENT DOMINATES THE ASIA IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 112: SYSTEMIC TOXICITY, THE LARGEST TOXICITY ENDPOINTS & TESTS SEGMENT IN ASIA IN 2016
  • FIGURE 113: OMICS TECHNOLOGIES SEGMENT COMMANDS LARGEST SHARE OF THE ASIA MARKET IN 2016
  • FIGURE 114: IN SILICO METHODS, THE LARGEST METHODS SEGMENT IN ASIA
  • FIGURE 115: COSMETICS & HOUSEHOLD PRODUCTS SEGMENT COMMANDS LARGEST SHARE OF THE ASIA MARKET IN 2016
  • FIGURE 116: ROW: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT (2016)
  • FIGURE 117: ASSAYS, THE LARGEST PRODUCT SEGMENT IN ROW IN 2016
  • FIGURE 118: ADME SEGMENT DOMINATES THE ROW IN VITRO TOXICOLOGY TESTING MARKET
  • FIGURE 119: SYSTEMIC TOXICITY, THE LARGEST TOXICITY ENDPOINTS & TESTS SEGMENT IN ROW IN 2016
  • FIGURE 120: OMICS TECHNOLOGIES SEGMENT COMMANDS LARGEST SHARE OF THE ROW MARKET IN 2016
  • FIGURE 121: IN SILICO METHODS, THE LARGEST METHODS SEGMENT IN ROW
  • FIGURE 122: COSMETICS & HOUSEHOLD PRODUCTS SEGMENT COMMANDS LARGEST SHARE OF THE ROW MARKET IN 2016
  • FIGURE 123: KEY DEVELOPMENTS IN THE IN VITRO TOXICOLOGY TESTING MARKET, 2013-2016
  • FIGURE 124: TOP COMPANIES IN THE IN VITRO TOXICOLOGY TESTING MARKET, 2016
  • FIGURE 125: FINANCIAL PERFORMANCES OF LEADING MARKET PLAYERS, 2015
  • FIGURE 126: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 127: LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
  • FIGURE 128: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 129: GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
  • FIGURE 130: EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
  • FIGURE 131: MERCK KGAA (PARENT COMPANY OF BIORELIANCE): COMPANY SNAPSHOT
  • FIGURE 132: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 133: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • FIGURE 134: CATALENT: COMPANY SNAPSHOT
  • FIGURE 135: CYPROTEX: COMPANY SNAPSHOT
Back to Top